Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...
Widely-used eye ointments can cause glaucoma implants to swell and potentially rupture, according to new research from Nagoya ...
Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...